| ASSET | YEARS | % RETURN |
|---|---|---|
Mesoblast (MESO) | 2008-2022 | 5,819,900% |
Cenntro Electric (CENN) | 2008-2022 | 5,764,092.14% |
Astrana Health (ASTH) | 2008-2022 | 2,958,900% |
ACCESS Newswire (ACCS) | 2008-2022 | 2,782,122.22% |
QXO (QXO) | 2008-2022 | 2,082,266.67% |
Avita Medical (RCEL) | 2008-2022 | 1,649,900% |
Akari Therapeutics (AKTX) | 2008-2022 | 1,503,900% |
Altimmune (ALT) | 2008-2022 | 1,028,025% |
Evogene (EVGN) | 2008-2022 | 999,900% |
Nocera (NCRA) | 2008-2022 | 959,900% |
Lunai Bioworks (LNAI) | 2008-2022 | 876,495.74% |
Lexaria Bioscience (LEXX) | 2008-2022 | 768,650% |
MDxHealth (MDXH) | 2008-2022 | 734,344.44% |
Addex Therapeutics (ADXN) | 2008-2022 | 699,900% |
Metalla Royalty & Streaming (MTA) | 2008-2022 | 697,771.43% |
INVO Fertility (IVF) | 2008-2022 | 610,460.01% |
Ridgetech (RDGT) | 2008-2022 | 488,081.82% |
Scienture (SCNX) | 2008-2022 | 472,995.98% |
Addentax (ATXG) | 2008-2022 | 459,328.57% |
Fubotv (FUBO) | 2008-2022 | 347,900% |
Change Agents (CHGA) | 2008-2022 | 222,757.14% |
Xcel Brands (XELB) | 2008-2022 | 174,950% |
Immatics (IMTX) | 2008-2022 | 174,100% |
Beeline (BLNE) | 2008-2022 | 137,437.54% |
LiveOne (LVO) | 2008-2022 | 128,700% |